Objective To provide a greater understanding of the expectations, symptoms and impact of the menopause among women and their partners. Study design Three online surveys were conducted among women aged ≥45 years with menopause symptoms (currently or within previous 10 years). Two questionnaires focussed on symptoms and treatments and were conducted before (Survey 1, 2015; n = 1000) and after (Survey 2, 2016, n = 1000) publication of the National Institute for Health and Care Excellence (NICE) menopause guidelines. Survey 3 (2017) focussed on the psychosocial impact of the menopause and was also conducted among partners (women n = 650; partners n = 350). Results Women experienced an average of seven symptoms; 42% reported them to be worse than expected. Approximately one-fifth of women were not expecting common symptoms, such as sleep disturbance and cognitive problems, and were uncertain how long symptoms could last. A significant proportion of women reported negative effects on work and relationships. There was a reluctance to talk openly about the menopause or consult a healthcare professional (HCP). Partners expressed a desire to provide support but were unsure how to do so. Often women felt isolated and 41% considered the information and support available to them was insufficient. Only 3% of women were aware of the NICE guidelines but the majority (66%) were interested in learning more. Conclusions These findings underscore the knowledge gaps and lack of support for women impacted by the menopause. Improved HCP training and education is required to ensure that high-quality menopause support can be accessed as standard.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.